BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 28, 2013
View Archived Issues
Novartis presents highlights of fourth quarter 2012
Read More
Promising efficacy reported for veliparib in pancreatic cancer
Read More
ASG-5ME evaluated in patients with pancreatic ductal adenocarcinoma
Read More
New homoerythromycins reported by Luoyang Huizhong Animal Medicine
Read More
Amakem discloses novel protein kinase C inhibitors
Read More
Mochida Pharmaceutical discloses new PDE10A inhibitors
Read More
H. Lundbeck patents novel nAChR positive allosteric modulators
Read More
Novel orexin receptor antagonists presented by Taisho Pharmaceutical
Read More
Nanjing Sanhome Pharmaceutical synthesizes new tubulin polymerization inhibitors
Read More
New agents for HIV infection presented by Gilead Sciences
Read More
4CMenB demonstrates promising immunogenicity in phase III trials
Read More
Antisense Therapeutics begins phase II trial of ATL-1103
Read More
Antitope forms protein deimmunization agreement
Read More
SymBio completes phase II trial of antiemetic transdermal patch
Read More
FDA approves three alogliptin-based therapies for type 2 diabetes
Read More
Phase III trial compares linifanib and sorafenib in hepatocellular carcinoma
Read More
Threshold Pharmaceuticals begins phase III MAESTRO study in pancreatic cancer
Read More
Pharmstandard and Janssen Pharmaceutica collaborate on TB drugs
Read More
Seattle Genetics and Millennium begin phase III trial of Adcetris
Read More
Genzyme's sBLA for Lemtrada in relapsing MS accepted for review
Read More
FDA approves Prevnar 13 pneumococcal vaccine for older children and adolescents
Read More
Findings from phase II/III study of Anyara in renal cell carcinoma presented
Read More
PD-0332991 is well tolerated in patients with recurrent or refractory advanced HCC
Read More
FDA approves Gleevec for children with Ph+ ALL
Read More
OncoTherapy Science expands gastric cancer study of OTSGC-A24
Read More
Digna Biotech initiates phase I trial of gene therapy product for acute intermittent porphyria
Read More
Baxter to acquire hemophilia compound OBI-1
Read More
